Regulation of volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following activation of lysophospholipid receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 2, 2006, Pages 685-693

  Heacock, Anne M ^a   Dodd, Michael S ^a   Fisher, Stephen K ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CHELERYTHRINE; CYTOCHALASIN D; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID; LYSOPHOSPHOLIPID RECEPTOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TAURINE; THAPSIGARGIN; TOXIN;

AMINO ACID TRANSPORT; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; OSMOREGULATION; OSMOTIC STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM;

CALCIUM; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SIZE; ENZYME INHIBITORS; HUMANS; LYSOPHOSPHOLIPIDS; NEUROBLASTOMA; OSMOTIC PRESSURE; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTORS, LYSOPHOSPHOLIPID; TAURINE;

EID: 33645841963     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.098467     Document Type: Article

References (39)

1. Cheema TA, Ward CE, and Fisher SK (2005) Subnanomolar concentrations of thrombin enhance the volume-sensitive efflux of taurine from human 1321N1 astrocytoma cells. J Pharmacol Exp Ther 315:755-763.
2. Contos JJA, Ishii I, and Chun J (2000) Lysophosphatidic acid receptors. Mol Pharmacol 58:1188-1196.
3. cl,swell and prevents swelling-induced shortening of guinea-pig atrial action potential duration. Br J Pharmacol 134:1467-1479.
4. 2+ requirements for phospholipase C activation. Mol Pharmacol 35:195-204.
5. Heacock AM, Dodd MS, and Fisher SK (2006) Regulation of osmolyte efflux by lysophospholipid receptors. J Neurochem (Suppl), in press.
6. 3 muscarinic cholinergic receptors. J Pharmacol Exp Ther 311:1097-1104.
7. Kimelberg HK (2000) Cell volume in the CNS: regulation and implications for nervous system function and pathology. The Neuroscientist 6:14-25.
8. Kostenis E (2004) Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine and (lyso)-phosphatidic acid: new receptors for "old" ligands. J Cell Biochem 92:923-936.
9. Lambert IH (2004) Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem Res 29:27-63.
10. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, and Haussinger D (1998) Functional significance of cell volume regulatory mechanisms. Physiol Rev 78:247-306.
11. 3 muscarinic receptors induces phosphorylation of the Cdc42 effector-activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathway. J Biol Chem 276:5622-5628.
12. Linseman DA, Hoffman F, and Fisher SK (2000) A role for the small molecular weight GTPases, Rho and Cdc42 in muscarinic receptor signaling to focal adhesion kinase. J Neurochem 74:2010-2020.
13. Linseman DA, McEwen EL, Sorensen SD, and Fisher SK (1998) Cytoskeletal and phosphoinositide requirements for muscarinic receptor signaling to focal adhesion kinase and paxillin. J Neurochem 70:940-950.
14. Loveday D, Heacock AM, and Fisher SK (2003) Activation of muscarinic cholinergic receptors enhances the volume-sensitive efflux of myo-inositol from SH-SY5Y neuroblastoma cells. J Neurochem 87:476-486.
15. Lynch KR and Im D-S (1999) Life on the edg. Trends Pharmacol Sci 20:473-475.
16. McManus ML, Churchwell KB, and Strange K (1995) Regulation of cell volume in health and disease. N Engl J Med 333:1260-1266.
17. Meyer zu Heringdorf D, Lass H, Kuchar I, Lipinski M, Alemany R, Rumenapp U, and Jakobs KH (2001) Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. Eur J Pharmacol 414:145-154.
18. Meyer zu Heringdorf D, Van Koppen CJ, Windorfer B, Himmel HM, and Jakobs KH (1996) Calcium signaling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells. Naunyn-Schmiedeberg's Arch Pharmacol 354:397-403.
19. Mongin AA and Kimelberg HK (2002) ATP potently modulates anion channelmediated excitatory amino acid release from cultured astrocytes. Am J Physiol 283:C569-C578.
20. 2+-sensitive mechanisms. Am J Physiol 288:C204-C213.
21. Moolenaar WH, van Meeteren LA, and Giepmans BNG (2004) The ins and outs of lysophosphatidic acid signaling. BioEssays 26:870-881.
22. Niedernberg A, Tunaru S, Blaukat A, Ardati A, and Kostenis E (2003) Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cell Signal 15:435-446.
23. Nilius B and Droogmans G (2003) Amazing chloride channels: an overview. Acta Physiol Scand 177:119-147.
24. Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, and Droogmans G (1997) Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol 68:69-119.
25. Novak JE, Agranoff BW, and Fisher SK (2000) Regulation of myo-inositol homeostasis in differentiated human NT2-N neurons. Neurochem Res 25:561-566.
26. Novak JE, Turner RS, Agranoff BW, and Fisher SK (1999) Differentiated human NT2-neurons possess a high intracellular content of myo-inositol. J Neurochem 72:1431-1440.
27. Pasantes-Morales H, Cardin V, and Tuz K (2000) Signaling events during swelling and regulatory volume decrease. Neurochem Res 25:1301-1314.
28. Pasantes-Morales H, Franco R, Ordaz B, and Ochoa LD (2002) Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res 33:237-244.
29. 2+ signalling. Assay Drug Dev Technol 1:31-40.
30. Spiegel S and Milstien S (2002) Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 277:25851-25854.
31. Spiegel S and Milstien S (2003) Sphingosine 1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407.
32. Strange K, Morrison R, Shrode L, and Putnam R (1993) Mechanism and regulation of swelling-activated inositol efflux in brain glial cells. Am J Physiol 265:C244-C256.
33. 2+ entry at plasma membrane in Jurkat human T-cells. Biochem J 319:393-397.
34. Thompson AK and Fisher SK (1990) Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas:methodological considerations. J Pharmacol Exp Ther 252: 744-752.
35. Toman RE and Spiegel S (2002) Lysophospholipid receptors in the nervous system. Neurochem Res 27:619-627.
36. 2+ signaling pathway in human neuroblastoma cells. J Neurosci Res 73:215-226.
37. Wojcikiewicz RJH, Furuichi T, Nakade S, Mikoshiba K, and Nahorski SR (1994) Muscarinic receptor activation down-regulates the type 1 inositol-1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem 269:7963-7969.
38. 2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of EDG-4 receptors. J Biol Chem 275:38532-38539.
39. 2+ mobilization in human SH-SY5Y neuroblastoma cells is independent of phosphoinositide signaling, but dependent on sphingosine kinase activation. Biochem J 343:45-52.